Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
NEW YORK and WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage..
NEW YORK and WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage..
· *Phase 2 study to assess updated formulations for improved immune responses of multivalent vaccine candidate against influenza B..
THE BLACK TAPE PROJECT NEW YORK FASHION WEEK RUNWAY SHOW BY ART HEARTS